Factors determining the efficacy of nuclear delivery of antisense oligonucleotides by gold nanoparticles.
about
Therapeutic Oligonucleotides Targeting Liver Disease: TTR AmyloidosisProgress in antiretroviral drug delivery using nanotechnologyPeptide antisense nanoparticles.Selective enhancement of nucleases by polyvalent DNA-functionalized gold nanoparticles.Rational design of gold nanocarrier for the delivery of JAG-1 peptide.Investigation of Sub-100 nm Gold Nanoparticles for Laser-Induced Thermotherapy of CancerFunctionalized gold nanoparticles for the binding, stabilization, and delivery of therapeutic DNA, RNA, and other biological macromoleculesTherapeutic potential of splice-switching oligonucleotides.Biological barriers to therapy with antisense and siRNA oligonucleotides.Targeting cancer with 'smart bombs': equipping plant virus nanoparticles for a 'seek and destroy' mission.Nanoparticle-based vaginal drug delivery systems for HIV prevention.A comparison of peptide and folate receptor targeting of cancer cells: from single agent to nanoparticle.Monolayer coated gold nanoparticles for delivery applicationsTracking the down-regulation of folate receptor-α in cancer cells through target specific delivery of quantum dots coupled with antisense oligonucleotide and targeted peptide.Multifunctional nanocarrier based on clay nanotubes for efficient intracellular siRNA delivery and gene silencing.Peptide-functionalized gold nanoparticles: versatile biomaterials for diagnostic and therapeutic applications.
P2860
Q26782089-FFAAE55F-9508-450A-AC9D-A25D5B7207B4Q30395011-5AD9936D-1FBA-4532-9326-7D99339FFA08Q30484525-0451A676-D9CF-463E-9E91-7E018FB367D9Q34846505-F35F531B-992C-4251-B751-C7DF83D05BC7Q35748112-23F86279-0038-4334-B586-BD7220C44F95Q36324653-2C414485-3ACE-4B6C-9FDF-BC0704EDF1D6Q37194010-813C209C-81A4-4F06-9EBA-3FA66F91DA3DQ37363171-35B74641-2838-4DDD-966F-B686775E9AB8Q37378340-24634812-836C-4565-89DF-FC4D49242943Q37538780-6FFF7961-A723-4EAD-A6B0-B173B22638EBQ37657512-02B1F77C-AD53-4FF1-B0FF-110CD2D59846Q37838443-6F69EF9A-06FC-4D81-9283-B69B5FB08476Q37934050-3F64141F-1FE8-45E2-969F-82C6360F6251Q38314361-2FD1CE86-FDE2-40A4-A7F7-06C8AE3BA1EEQ39103742-36A14003-C0F5-4F8B-A33A-DF7DB9A4DB35Q39183488-8D76B207-307F-4E69-A59A-0C22E4DFCA7E
P2860
Factors determining the efficacy of nuclear delivery of antisense oligonucleotides by gold nanoparticles.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh-hant
name
Factors determining the effica ...... eotides by gold nanoparticles.
@en
Factors determining the effica ...... eotides by gold nanoparticles.
@nl
type
label
Factors determining the effica ...... eotides by gold nanoparticles.
@en
Factors determining the effica ...... eotides by gold nanoparticles.
@nl
prefLabel
Factors determining the effica ...... eotides by gold nanoparticles.
@en
Factors determining the effica ...... eotides by gold nanoparticles.
@nl
P356
P1476
Factors determining the effica ...... eotides by gold nanoparticles.
@en
P2093
Stefan Franzen
P304
P356
10.1021/BC700421U
P577
2008-04-05T00:00:00Z